Biotechnology Today
more-
The shopping spree continues: DJO acquires Switzerland’s Mathys to grow global orthopedics footprint
DJO Global is putting the “therapy” in retail therapy: The surgical device maker has now…
FDA approves Medtronic’s long-lasting Vanta spinal cord stimulator
Acumen rides aducanumab, amyloid and Alzheimer’s waves on its IPO voyage
Inogen snags BD diabetes VP for CMO to help expand line of home oxygen devices
FDA clears CyMedica’s app-connected muscle stimulation system to treat osteoarthritic knee pain
Markets
more-
Weekly Market Review – June 19, 2021
Stock Markets Throughout the past week, the stock markets surprisingly declined due to the Federal…
Bio Space
more
Kurome raises $15M to overcome adaptive resistance in leukemia
Kurome Therapeutics has raised $15 million to treat acute myeloid…
Bright Peak bags $107M to bankroll ‘conveyor belt’ of cytokine programs
Nearly a year after emerging from a Versant Ventures incubator,…
Senda drives 3 programs toward clinic with bumped-up $98M series B
Flagship Pioneering united its “intersystems biology” efforts under one roof…
Global News
more
SpaceX Starlink wins permit to send internet to customers like you
SpaceX has been busy building its Starlink satellite constellation. To…
Facebook video calls soar 1000% during Italy’s lockdown
Facebook has seen usage across its platforms surge in countries…
WeWork board’s special committee is demanding that SoftBank follow through with investment
Five months after SoftBank agreed to a massive bailout of…
Weekly Market Review – June 19, 2021
The shopping spree continues: DJO acquires Switzerland’s Mathys to grow global orthopedics footprint
FDA approves Medtronic’s long-lasting Vanta spinal cord stimulator
Acumen rides aducanumab, amyloid and Alzheimer’s waves on its IPO voyage
Inogen snags BD diabetes VP for CMO to help expand line of home oxygen devices
Kurome raises $15M to overcome adaptive resistance in leukemia
Bright Peak bags $107M to bankroll ‘conveyor belt’ of cytokine programs
Senda drives 3 programs toward clinic with bumped-up $98M series B
Investor interest in Alzheimer’s ‘changed on the dime’ following FDA’s decision on Biogen’s aducanumab
FDA clears CyMedica’s app-connected muscle stimulation system to treat osteoarthritic knee pain